NCT05494710

Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: South Tees Hospitals NHS Foundation Trust · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the BEST study is to examine the feasibility of assessing patient and clinician reported outcome of a single electrosclerotherapy treatment of vascular malformations. * Sclerotherapy = injection of Bleomycin into vascular birthmarks to seal off abnormal vascular channels * Electroporation = application of an electric field to vessels treated with a handheld needle electrode * Electrosclerotherapy = a combination of Bleomycin sclerotherapy and electroporation

Conditions

• Vascular Malformations

Interventions

Type	Name	Description
OTHER	Bleomycin electrosclerotherapy treatment	The combination of Bleomycin and electroporation of the treated area which is called electrochemotherapy (ECT).

Timeline

• Start date: 2020-12-01
• Primary completion: 2022-12-01
• Completion: 2022-12-01
• First posted: 2022-08-10
• Last updated: 2022-08-10

Locations

1 site across 1 country: United Kingdom